Aminoverse B.V. sell "Enzyme Discovery"

For a challenging, non-natural reaction, or an existing enzyme whose performance or stability falls short, this service uses the latest biophysics and machine learning technology to identify the right enzyme for the target reaction. Its proprietary EnzyNav AI platform helps find the most suitable enzyme out of more than 4 billion sequences, explores evolutionary trajectories and different enzyme structures, and helps ensure freedom to operate by selecting sequences outside the scope of known patents. Beyond identifying the right enzyme sequence, the company can supply enzyme powder and a turnkey solution including enzyme screening services and biocatalytic reaction development.